• SENSEX 80,332.32
    43.94 (+0.05%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Tata Motors
    641.10 542.55(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Trent
    5,134.00 4,058.45(%)
  • Bharat Electron
    312.50 221.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • ICICI Bank
    1,424.00 1,051.50(%)
  • Sonata Software
    415.25 762.00(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novelix Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 33252.0
  • ISIN : INE314I01036
26.61 0 (0.00%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    26.61

  • Today’s High

    26.61

  • Open

    26.61

  • Perv Close

    26.61

  • 52W Low

    17.19

  • 52W High

    26.61

Key Indicators

  • P/E(TTM)

    332.63

  • Mar.Cap (₹Cr.)

    66.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.62

  • Debt-Equity Ratio

    0.00

  • AGM Date

    28-Apr-2025

  • EPS

    0.08

  • P/E Ratio

    332.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    66.39

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.95

  • BV (₹)

    15.60

  • Sales( ₹ in Cr.)

    4.49

  • NP (in Cr.)

    -0.02

  • NP Var(%)

    63.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    66.39

  • 52 Week High

    26.61

  • 52 Week Low

    17.19

  • Price BSE

    27.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    66.39

  • P/C Ratio

    4,229.50

  • P/E Ratio

    -3,031.50

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 4.49 1.92 1.14 1.31 1.50 3.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.49 1.92 1.14 1.31 1.50 3.61
Other Income 0.04 0.00 0.25 0.00 0.00 0.11
Stock Adjustments 0.37 0.29 0.28 -0.14 -0.02 0.00
Total Income 4.90 2.21 1.67 1.17 1.48 3.72
EXPENDITURE :            
Raw Materials 4.21 1.64 1.09 0.88 0.73 2.77
Power and Fuel Cost 0.00 0.01 0.01 0.01 0.02 0.00
Employee Cost 0.13 0.16 0.14 0.15 0.13 0.18
Other Manufacturing Expenses 0.02 0.02 0.02 0.03 0.05 0.03
Selling and Administration Expenses 0.34 0.36 0.38 0.31 0.35 0.42
Miscellaneous Expenses 0.14 0.01 1.53 2.98 0.01 0.02
Employee Benefit Expenses 0.13 0.16 0.14 0.15 0.13 0.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4.85 2.21 3.17 4.36 1.29 3.41
Operating Profit 0.06 0.00 -1.49 -3.19 0.18 0.31
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.06 0.00 -1.49 -3.19 0.18 0.31
Depreciation 0.04 0.06 0.07 0.08 0.08 0.12
Profit Before Tax 0.02 -0.06 -1.56 -3.27 0.10 0.19
Current Tax 0.00 0.00 0.00 0.00 0.01 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.00 -0.01 0.00 0.01 -0.10
Reported Net Profit 0.01 -0.06 -1.56 -3.27 0.09 0.25
Extraordinary Items 0.03 0.00 -0.02 0.00 0.00 0.09
Adjusted Net Profit -0.02 -0.06 -1.54 -3.27 0.09 0.16
Adjustment below Net Profit 0.15 0.01 0.00 0.00 -0.03 -0.06
P & L Balance brought forward -2.43 -2.37 -0.81 2.53 2.50 2.25
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.14 0.01 0.00 0.07 0.03 -0.06
P & L Balance carried down -2.41 -2.43 -2.37 -0.81 2.53 2.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.01 -0.07 -1.93 -4.04 0.12 0.31
Earnings Per Share(Adj)-Unit Curr 0.01 -0.07 -1.93 -4.04 0.12 -
Book Value 9.08 8.88 8.94 10.87 14.90 14.83
Book Value(Adj)-Unit Curr 9.08 8.88 8.94 10.87 14.90 -

Shareholding Pattern

  • Promoter Group

    66.56%

  • Public Share Holding

    33.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,620,733 16.29 1,620,733 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 5,002,000 50.27 5,002,000 1
Sub Total 6,622,733 66.56 6,622,733 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,164,736 11.71 1,156,636 24
Clearing Members 1 0.00 1 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 31,929 0.32 31,929 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,083,985 10.89 1,049,285 19
Individuals holding nominal share capital up to Rs. 1 lakh 911,616 9.16 626,806 2,430
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 135,000 1.36 135,000 1
Sub Total 3,327,267 33.44 2,999,657 2,480
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,950,000 100.00 9,622,390 2,484

Company Background

Novelix Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Novelix Pharmaceuticals Ltd
  • BSE Code : 33252.0
  • ISIN : INE314I01036

  • Incorporation Year

    1994

  • Registered Office

    4-4-231/1/2/ABC Inderbagh
    Sultan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-24757370

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Nishita Kalantri

  • Auditor

    CVS Bala Chandra Rao & Co/P Murali & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Novelix Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novelix Pharma. 26.61 4.53 4.22 332.63 -0.24
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92